Concepedia

Silvia Damian

SD

17

Publications

1.9K

Citations

13

H-Index

2012

Active since

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

University of Milan

The University of Texas MD Anderson Cancer Center

Institut Gustave Roussy

Istituti di Ricovero e Cura a Carattere Scientifico

Silvia Damian is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, pathology, and oncology.

Top concepts

MedicineOncologyPathologyPharmacologyCancer TherapyCancer ResearchCancer Cell BiologyTumor BiologyMolecular OncologyRadiation Oncology

Publications per year

2012–2024

17

Publications

17

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)

Alexander Drilon, Salvatore Siena, Sai‐Hong Ignatius Ou et al. · Cancer Discovery · 2017 · 795 citations · Full text

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Robin Kate Kelley, Bruno Sangro, William Proctor Harris et al. · Journal of Clinical Oncology · 2021 · 427 citations · Full text

Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma

Roger B. Cohen, Jean‐Pierre Delord, Toshihiko Doi et al. · American Journal of Clinical Oncology · 2018 · 202 citations · Full text

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer

Patrick Schöffski, Sara Cresta, Ingrid A. Mayer et al. · Breast Cancer Research · 2018 · 87 citations · Full text

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

Cecilia Carpio, Réda Bouabdallah, Loïc Ysebaert et al. · Blood · 2020 · 69 citations · Full text

Rows per page

1–5 of 17